Published in Medical Letter on the CDC and FDA, February 18th, 2001
"The emergence of drug-resistant strains of bacteria has complicated treatment decisions and may lead to treatment failures," wrote C.G. Whitney and colleagues, CDC, Atlanta, Georgia. "We examined data on invasive pneumococcal disease in patients identified from 1995 to 1998 in the Active Bacterial Core Surveillance program of the CDC. Pneumococci that had a high level of resistance or had intermediate resistance according to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.